Jpmorgan Chase & CO Balchem Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Balchem Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 479,737 shares of BCPC stock, worth $76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

479,737

Previous 509,490 5.84%

Holding current value

$76 Million

Previous $83 Million 4.11%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$154.22 - $176.16 $4.59 Million - $5.24 Million	-29,753 Reduced 5.84%	479,737 $79.6 Million
Q4 2024 Feb 12, 2025	BUY	$163.0 - $183.41 $8.23 Million - $9.26 Million	50,504 Added 11.0%	509,490 $83 Million
Q3 2024 Dec 26, 2024	BUY	$154.1 - $181.56 $1.19 Million - $1.4 Million	7,721 Added 1.71%	458,986 $80.7 Million
Q3 2024 Nov 08, 2024	BUY	$154.1 - $181.56 $1.19 Million - $1.4 Million	7,721 Added 1.71%	458,986 $80.7 Million
Q2 2024 Dec 26, 2024	SELL	$138.5 - $156.63 $1.07 Million - $1.21 Million	-7,721 Reduced 1.68%	451,265 $69.5 Million
Q2 2024 Aug 12, 2024	SELL	$138.5 - $156.63 $4.03 Million - $4.56 Million	-29,091 Reduced 6.06%	451,265 $69.5 Million
Q1 2024 Dec 26, 2024	BUY	$137.06 - $157.27 $2.93 Million - $3.36 Million	21,370 Added 4.66%	480,356 $74.4 Million
Q1 2024 May 10, 2024	BUY	$137.06 - $157.27 $10.4 Million - $11.9 Million	75,633 Added 18.69%	480,356 $74.4 Million
Q4 2023 Dec 26, 2024	SELL	$115.08 - $150.35 $6.24 Million - $8.16 Million	-54,263 Reduced 11.82%	404,723 $60.2 Million
Q4 2023 Feb 12, 2024	BUY	$115.08 - $150.35 $9.51 Million - $12.4 Million	82,672 Added 25.67%	404,723 $60.2 Million
Q3 2023 Nov 14, 2023	BUY	$123.38 - $142.72 $32.7 Million - $37.8 Million	264,836 Added 462.88%	322,051 $39.9 Million
Q2 2023 Aug 11, 2023	BUY	$122.28 - $136.64 $40,841 - $45,637	334 Added 0.59%	57,215 $7.71 Million
Q1 2023 May 18, 2023	BUY	$117.39 - $142.06 $4.97 Million - $6.02 Million	42,375 Added 292.12%	56,881 $7.19 Million
Q1 2023 May 11, 2023	SELL	$117.39 - $142.06 $3.74 Million - $4.53 Million	-31,875 Reduced 68.72%	14,506 $1.83 Million
Q4 2022 Feb 13, 2023	SELL	$120.16 - $142.73 $797,501 - $947,299	-6,637 Reduced 12.52%	46,381 $5.66 Million
Q3 2022 Nov 14, 2022	BUY	$119.7 - $141.48 $237,724 - $280,979	1,986 Added 3.89%	53,018 $6.45 Million
Q2 2022 Aug 11, 2022	SELL	$113.6 - $139.82 $536,646 - $660,509	-4,724 Reduced 8.47%	51,032 $6.62 Million
Q1 2022 May 11, 2022	SELL	$131.21 - $167.55 $1.49 Million - $1.9 Million	-11,324 Reduced 16.88%	55,756 $7.62 Million
Q4 2021 Feb 10, 2022	BUY	$149.18 - $172.5 $5.78 Million - $6.68 Million	38,718 Added 136.51%	67,080 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$129.2 - $150.61 $3.66 Million - $4.27 Million	28,362 New	28,362 $4.12 Million

Others Institutions Holding BCPC

# of Institutions

421

Shares Held

28.6M

Call Options Held

64.8K

Put Options Held

6.2K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.09B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Balchem Corp Transaction History